NEOPLASIE CEREBRALI PRIMITIVE: RISULTATI PRELIMINARI DI UN TRATTAMENTO INTEGRATO MULTIDISCIPLINARE = TUMEURS CEREBRALES PRIMITIVES: RESULTATS PRELIMINAIRES D'UN TRAITEMENT MULTIDISCIPLINAIRECOMELLA G; TEDESCHI G; COMELLA P et al.1980; GAZZ. MED. ITAL.; ISSN 0016-5670; ITA; DA. 1980; VOL. 139; NO 7-8; PP. 407-412; ABS. ENG; BIBL. 25 REF.Article

The Arabidopsis thaliana genome projectDELSENY, M; COOKE, R; COMELLA, P et al.Comptes rendus de l'Académie des sciences. Série 3, Sciences de la vie. 1997, Vol 320, Num 8, pp 589-599, issn 0764-4469Article

Treatment of resistant non-Hodgkin's lymphomas with cisplatin, etoposide, and bleomycinCOMELLA, P; ABATE, G; DI FINIZIO, G et al.Cancer chemotherapy and pharmacology. 1990, Vol 26, Num 4, pp 306-309, issn 0344-5704, 4 p.Article

A risk model for ovarian carcinoma patients using CA 125 : Time to normalization renders second-look laparotomy redundantFRASCI, G; CONFORTI, S; ZULLO, F et al.Cancer. 1996, Vol 77, Num 6, pp 1122-1130, issn 0008-543XArticle

Treatment of advanced urothelial carcinoma with M-VECA (methotrexate, vinblastine, epirubicin and carboplatin)LORUSSO, V; PAGLIARULO, A; SELVAGGI, F. P et al.Journal of chemotherapy. 1996, Vol 8, Num 2, pp 154-158, issn 1120-009XArticle

Intraperitoneal adjuvant immunochemotherapy in operable gastric cancer with serosal involvementFRASCI, G; IAFFAIOLI, R. V; COMELLA, G et al.Clinical oncology (Springer. Print). 1994, Vol 6, Num 6, pp 364-370, issn 0936-6555Conference Paper

Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancerCAPONIGRO, F; COMELLA, P; BUDILLON, A et al.Annals of oncology. 2000, Vol 11, Num 3, pp 339-342, issn 0923-7534Article

Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer : A phase I studyFRASCI, G; COMELLA, P; SCOPPA, G et al.Journal of clinical oncology. 1997, Vol 15, Num 4, pp 1409-1417, issn 0732-183XArticle

Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients : a Southern Italy Cooperative Oncology Group phase II studyCOMELLA, P; MASSIDDA, B; PALMERI, S et al.Cancer chemotherapy and pharmacology. 2005, Vol 56, Num 5, pp 481-486, issn 0344-5704, 6 p.Article

Significance of methotrexate serum level achieved in patients with gastrointestinal malignancies treated with sequential methotrexate, L-folinic acid and 5-fluorouracilCOMELLA, P; PALMIERI, G; BENEDUCE, G et al.Oncology. 1996, Vol 53, Num 3, pp 198-203, issn 0030-2414Article

Irinotecan plus leucovorin-modulated 5-fluorouracil I.V. bolus every other week may be a suitable therapeutic option also for elderly patients with metastatic colorectal carcinomaCOMELLA, P; FARRIS, A; LORUSSO, V et al.British journal of cancer. 2003, Vol 89, Num 6, pp 992-996, issn 0007-0920, 5 p.Article

Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients : A parallel dose-finding studyFRASCI, G; COMELLA, P; VALLONE, P et al.Annals of oncology. 2000, Vol 11, Num 3, pp 367-371, issn 0923-7534Article

Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma : A Southern Italy cooperative oncology group phase II-III randomized trialCOMELLA, P; DE VITA, F; CARTENI, G et al.Annals of oncology. 2000, Vol 11, Num 10, pp 1323-1333, issn 0923-7534Article

A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neckCAPONIGRO, F; COMELLA, P; MARCOLIN, P et al.Cancer. 1999, Vol 85, Num 4, pp 952-959, issn 0008-543XArticle

Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancerCAPONIGRO, F; AVALLONE, A; GRAVINA, A et al.Clinical cancer research. 1999, Vol 5, Num 12, pp 3948-3955, issn 1078-0432Article

Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patientsCOMELLA, P; FRASCI, G; CIOFFI, R et al.British journal of cancer. 2004, Vol 91, Num 3, pp 489-497, issn 0007-0920, 9 p.Article

Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck : A phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG)CAPONIGRO, F; COMELLA, P; COMELLA, G et al.Annals of oncology. 2000, Vol 11, Num 5, pp 575-580, issn 0923-7534Article

Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients : A dose-finding studyFRASCI, G; PANZA, N; GRAVINA, A et al.Annals of oncology. 1999, Vol 10, Num 3, pp 355-358, issn 0923-7534Article

Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma : A phase I study of the Southern Italy Cooperative Oncology GroupCOMELLA, P; CASARETTI, R; CATALANO, G et al.Annals of oncology. 1999, Vol 10, Num 8, pp 915-921, issn 0923-7534Article

Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology GroupCOMELLA, P; CRUCITTA, E; MAIORINO, L et al.Annals of oncology. 2002, Vol 13, Num 6, pp 866-873, issn 0923-7534Article

Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer : a phase I-II studyAVALLONE, A; DELRIO, P; BUDILLON, A et al.British journal of cancer. 2006, Vol 94, Num 12, pp 1809-1815, issn 0007-0920, 7 p.Article

Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer : final analysis of a sicog phase III studyFRASCI, G; D'AIUTO, G; COMELLA, P et al.British journal of cancer. 2006, Vol 95, Num 8, pp 1005-1012, issn 0007-0920, 8 p.Article

Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck : A phase II study of the Southern Italy Cooperative Oncology Group (SICOG)CAPONIGRO, F; MASSA, E; MANTOVANI, G et al.Annals of oncology. 2001, Vol 12, Num 2, pp 199-202, issn 0923-7534Article

Fotemustine and dacarbazine plus recombinant interferon alpha2a in the treatment of advanced melanomaCOMELLA, P; DAPONTE, A; MOZZILLO, N et al.European journal of cancer (1990). 1997, Vol 33, Num 8, pp 1326-1329, issn 0959-8049Article

Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: A phase I studyFRASCI, G; PANZA, N; COMELLA, P et al.Annals of oncology. 1997, Vol 8, Num 10, pp 1045-1048, issn 0923-7534Article